ePRO Resources

  1. Empowering Oncology Research With The Right Technology Solutions 10/25/2023

    Explore how advanced technology solutions have the potential to simplify the operational aspects of oncology trials.

  2. Considerations For Implementing The Best eCOAs In Your Trial Design 5/2/2022

    Dive into considerations when deciding on the best COAs to implement as well as best practices when developing your eCOA strategy in this blog.

  3. Focusing On Patient-Reported Outcome Measures And eConsent 8/7/2023

    Learn how digital solutions can contribute to a more participant-centered approach and potentially enhance the regulatory utility of PRO data while improving the overall quality and efficiency of oncology trials.

  4. Solutions For Sponsors Utilizing Drafted Guidance For PROs In Oncology 11/20/2024

    Explore the challenges pharmaceutical companies face in implementing PROs in cancer clinical trials as outlined in the FDA’s draft guidance, as well as strategies to overcome these obstacles.

  5. Why Site Burden Goes Beyond eSource 6/12/2026

    Beth Harper explains why the real problem is broader than eSource and why sponsors should integrate around the systems sites already use.

  6. Addressing The Specific Complexities Of Oncology eCOA Clinical Trials 4/18/2022

    What are the specific tools and keys to conduct eCOA trials in oncology successfully? This article identifies some of the relevant solutions to tackle oncology protocol complexities.

  7. FDA's Vision On PRO Collection For RWE 9/24/2024

    In this presentation, a distinguished panel of experts illuminates the crucial role of patient-reported outcomes (PROs) in shaping regulatory decisions and drug development strategies.

  8. How Site And Patient Research Optimizes Clinical Trials 6/17/2024

    Signant’s patient and site research enhances digital health technology in clinical trials by optimizing usability and design. These insights drive improvements in product features, study designs, and training materials.

  9. Exploring The Potential Of Non-Consumer Smartphones In Clinical Trials 4/17/2024

    We selected and evaluated a non-consumer device, to explore its potential as a reliable tool for home-based ePRO measure administration. Here’s what we learned from this usability testing. 

  10. C3 Summit Recap: Shaping The Future Of eCOA/ePRO Highlights 2/10/2022

    Understand how the rapid shift to decentralized clinical trials required pharma companies and CROs to adapt data capture techniques quickly while remaining compliant with local regulations.